SARS-CoV-2 transmission in teenagers and young adults in Fútbol Club Barcelona's Multidisciplinary Sports Training Academy.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
May 2023
Historique:
received: 07 12 2022
accepted: 14 02 2023
revised: 13 02 2023
medline: 15 5 2023
pubmed: 15 3 2023
entrez: 14 3 2023
Statut: ppublish

Résumé

Most studies, aimed at determining the incidence and transmission of SARS-CoV-2 in children and teenagers, have been developed in school settings. Our study conducted surveillance and inferred attack rates focusing on the practice of sports. Prospective and observational study of those attending the sports facilities of Fútbol Club Barcelona (FCB), in Barcelona, Spain, throughout the 2020-2021 season. Participants were young players (from five different sports) and adult workers, who belonged to stable teams (shared routines and were involved in same quarantine rules). Biweekly health questionnaires and SARS-CoV-2 screening were conducted. From the 234 participants included, 70 (30%) both lived and trained in the FCB facilities (Recruitment Pathway 1;RP1) and 164 (70%) lived at their own household and just came to the facilities to train (RP2). During the study, 38 positive cases were identified; none had severe symptoms or needed hospitalization. The overall weekly incidence in the cohorts did not differ compared to the one expected in the community, except for 2 weeks when an outbreak occurred. The attack rate (AR) was three times higher for the participants from RP1, in comparison to those from RP2 (p < 0.01). A Basketball team showed a significant higher AR.  Conclusion: Physical activities in stable teams are not related to an increased risk of transmission of SARS-CoV-2, since there were the same observed cases than expected in the community. The risk is higher in indoor sports (Basketball vs. Football), and in closed cohort living settings (RP1 vs. RP2). The fulfilment of preventive measures is essential. What is Known: • Despite the low numerical impact caused in paediatric hospitalizations during COVID-19 pandemic, the social impact has been maximum. • The transmission potential in children and teenagers is limited, and it had been widely demonstrated in school settings. What is New: • Group physical activities in children and teenagers are not also related to an increased risk of transmission of SARS-CoV-2, when preventive measures, such as washing hands, and screening protocols are applied. • Routine and semi-professional sports activities seem safe environments to promote during this pandemic.

Identifiants

pubmed: 36914778
doi: 10.1007/s00431-023-04880-x
pii: 10.1007/s00431-023-04880-x
pmc: PMC10010953
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2421-2432

Informations de copyright

© 2023. The Author(s).

Références

Biomed Pharmacother. 2021 Nov;143:112176
pubmed: 34562770
J Athl Train. 2021 Nov 18;:
pubmed: 34793596
Sports Health. 2021 Jan/Feb;13(1):15-17
pubmed: 32986534
JAMA Netw Open. 2022 Feb 1;5(2):e2147810
pubmed: 35138404
Clin Exp Pediatr. 2020 Apr;63(4):125-132
pubmed: 32252139
Epidemiology. 2022 Mar 1;33(2):193-199
pubmed: 34483266
Front Public Health. 2021 Nov 25;9:746052
pubmed: 34900898
Acta Biomed. 2020 May 11;91(2):172-176
pubmed: 32420941
JAMA Netw Open. 2021 Oct 1;4(10):e2135566
pubmed: 34714347
Pediatr Clin North Am. 2021 Oct;68(5):945-959
pubmed: 34538305
Lancet. 2021 Mar 20;397(10279):1037-1039
pubmed: 33743854
BMC Infect Dis. 2021 Aug 30;21(1):889
pubmed: 34461847
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
Pediatr Infect Dis J. 2021 Nov 1;40(11):955-961
pubmed: 34321438
Am Fam Physician. 2021 Apr 15;103(8):465-472
pubmed: 33856162
Lancet Infect Dis. 2021 Mar;21(3):298-299
pubmed: 33306982
Sci Rep. 2021 Jul 6;11(1):13903
pubmed: 34230530
Med J Armed Forces India. 2021 Jul;77:S379-S384
pubmed: 34334907
Br J Sports Med. 2021 Jan;55(1):62-66
pubmed: 32972979
Emerg Microbes Infect. 2021 Dec;10(1):152-160
pubmed: 33407005
Int J Environ Res Public Health. 2020 Apr 22;17(8):
pubmed: 32331344
Sports Health. 2020 Nov/Dec;12(6):518-520
pubmed: 32816648
Lancet Infect Dis. 2020 Jun;20(6):633-634
pubmed: 32220651
Int J Infect Dis. 2021 Sep;110:363-370
pubmed: 34320412
Arch Dis Child. 2020 Jul;105(7):618-619
pubmed: 32371442
Arch Comput Methods Eng. 2021;28(6):4297-4316
pubmed: 34226815
J Pediatr (Rio J). 2022 Mar-Apr;98 Suppl 1:S4-S12
pubmed: 34571018
BMC Public Health. 2020 Sep 4;20(1):1351
pubmed: 32887592
Orthop J Sports Med. 2021 Jan 29;9(1):2325967121992045
pubmed: 33614804
J Formos Med Assoc. 2020 Mar;119(3):670-673
pubmed: 32139299
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Sci Rep. 2021 Nov 3;11(1):21571
pubmed: 34732749
J Athl Train. 2022 Jan 1;57(1):59-64
pubmed: 34129671

Auteurs

María Hernández-García (M)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain.

Quique Bassat (Q)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain.
ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigação Em Saúde de Manhiça (CISM), Maputo, Mozambique.
Catalan Institution for Research and Advanced Studies, ICREA, Barcelona, Spain.

Victoria Fumado (V)

Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Infectious Diseases Department, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Gil Rodas (G)

Sports Medicine Unit, Hospital Clinic and Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Medical Department, Futbol Club Barcelona, Barça Innovation Hub, Barcelona, Spain.

Ramon Pi (R)

Medical Department, Futbol Club Barcelona, Barça Innovation Hub, Barcelona, Spain.

Maite Miranda-Garcia (M)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Fundació Sant Joan de Déu, Barcelona, Spain.

Mònica Girona-Alarcón (M)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Paediatric Intensive Care Unit, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Martí Català (M)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.

Sergio Alonso (S)

Computational Biology and Complex Systems (BIOCOM-SC), Department of Physics, Universitat Politècnica de Catalunya, Castelldefels, Spain.

Enrique Alvarez-Lacalle (E)

Computational Biology and Complex Systems (BIOCOM-SC), Department of Physics, Universitat Politècnica de Catalunya, Castelldefels, Spain.

Daniel López (D)

Computational Biology and Complex Systems (BIOCOM-SC), Department of Physics, Universitat Politècnica de Catalunya, Castelldefels, Spain.

Maria Melé-Casas (M)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain.

Gemma Pons-Tomas (G)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain.

Mariona F de Sevilla (M)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Elisenda Bonet-Carne (E)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
BCNatal Fetal Medicine Research Center, Hospital Clinic and Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Institut d Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Universitat Politècnica de Catalunya • BarcelonaTech, Barcelona, Spain.

Claudia Fortuny (C)

Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Infectious Diseases Department, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Aleix García-Miquel (A)

Fundació Sant Joan de Déu, Barcelona, Spain.
BCNatal Fetal Medicine Research Center, Hospital Clinic and Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Cristina Jou (C)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Department of Pathology and Biobank, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER), Instituto de Salud Carlos III, Madrid, Spain.

Cristina Adroher (C)

Strategic Planning and Management Control, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Joana Claverol (J)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Fundació Sant Joan de Déu, Barcelona, Spain.

Marta Cubells (M)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Fundació Sant Joan de Déu, Barcelona, Spain.

Anna Codina (A)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Department of Pathology and Biobank, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Daniel Cuadras (D)

Statistics Department, Fundació Sant Joan de Déu, Barcelona, Spain.

Eduard Gratacós (E)

Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
BCNatal Fetal Medicine Research Center, Hospital Clinic and Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Institut d Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER), Instituto de Salud Carlos III, Madrid, Spain.

Pedro Brotons (P)

Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Department of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.

Carmen Muñoz-Almagro (C)

Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Department of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.
RDI Microbiology Department, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Clara Prats (C)

Computational Biology and Complex Systems (BIOCOM-SC), Department of Physics, Universitat Politècnica de Catalunya, Castelldefels, Spain.

Juan José García-García (JJ)

Paediatrics Department, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, Number 2, Barcelona, Esplugues de Llobregat, 08950, Spain. juanjo_garcia@ub.edu.
Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain. juanjo_garcia@ub.edu.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain. juanjo_garcia@ub.edu.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain. juanjo_garcia@ub.edu.

Iolanda Jordan (I)

Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.
Infectious Diseases and Microbiome, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.
Paediatric Intensive Care Unit, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH